Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Oric Pharmaceuticals, Inc. (ORIC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "ORIC PHARMACEUTICALS, INC. CONDENSED BALANCE SHEETS Assets Current assets: Cash, cash equivalents and short-term investments $ 264,159 $ 206,272 Prepaid expenses and other current assets 4,199 4,185 Total current assets 268,358 210,457 Long-term investments 9,575 21,951 Property and equipment, net 3,250 3,253 Other assets 10,633 11,517 Total assets $ 291,816 $ 247,178 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 3,191 $ 1,320 Accrued liabilities 11,343 14,068 Total current liabilities 14,534 15,388 Other long-term liabilities 8,483 9,439 Total liabilities 23,017 24,827 Total stockholders' equity 268,799 222,351 Total liabilities and stockholders' equity $ 291,816 $ 247,178 ORIC PHARMACEUTICALS, INC. STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Three Mon..."
07/11/2023 4 Chacko Jacob (President and CEO) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Sold 10,508 shares @ $8.0141, valued at $84.2k
Sold 5,156 shares @ $8.0076, valued at $41.3k
07/07/2023 4 Chacko Jacob (President and CEO) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Sold 4,336 shares @ $8.0052, valued at $34.7k
07/07/2023 SC 13G Nextech Crossover I GP S.a r.l. reports a 7.9% stake in ORIC Pharmaceuticals, Inc.
07/05/2023 144 Form 144 - Report of proposed sale of securities:
07/05/2023 D Form D - Notice of Exempt Offering of Securities:
06/28/2023 4 Chacko Jacob (President and CEO) has filed a Form 4 on Oric Pharmaceuticals, Inc.
Txns: Sold 20,000 shares @ $8.0281, valued at $160.6k
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/08/2023 8-K Quarterly results
Docs: "ORIC PHARMACEUTICALS, INC. CONDENSED BALANCE SHEETS Assets Current assets: Cash, cash equivalents and short-term investments $ 189,629 $ 206,272 Prepaid expenses and other current assets 3,535 4,185 Total current assets 193,164 210,457 Long-term investments 19,309 21,951 Property and equipment, net 3,112 3,253 Other assets 11,063 11,517 Total assets $ 226,648 $ 247,178 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 1,930 $ 1,320 Accrued liabilities 12,937 14,068 Total current liabilities 14,867 15,388 Other long-term liabilities 8,969 9,439 Total liabilities 23,836 24,827 Total stockholders' equity 202,812 222,351 Total liabilities and stockholders' equity $ 226,648 $ 247,178 ORIC PHARMACEUTICALS, INC. STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Three Mo..."
04/26/2023 ARS Form ARS - Annual Report to Security Holders:
04/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/24/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "Amended and Restated Bylaws",
"Amended and Restated Bylaws"
03/16/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/16/2023 10-K Annual Report for the period ended December 31, 2022
03/16/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "ORIC PHARMACEUTICALS, INC. CONDENSED BALANCE SHEETS December 31, 2022 2021 Assets Current assets: Cash, cash equivalents and short-term investments $ 206,272 $ 236,979 Prepaid expenses and other current assets 4,185 3,543 Total current assets 210,457 240,522 Long-term investments 21,951 43,386 Property and equipment, net 3,253 2,413 Other assets 11,517 12,321 Total assets $ 247,178 $ 298,642 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 1,320 $ 1,886 Accrued liabilities 14,068 13,265 Total current liabilities 15,388 15,151 Other long-term liabilities 9,439 10,515 Total liabilities 24,827 25,666 Total stockholders' equity 222,351 272,976 Total liabilities and stockholders' equity $ 247,178 $ 298,642 ORIC PHARMACEUTICALS, INC. STATEMENTS OF OPERATIONS AND COMPR..."
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A EcoR1 Capital, LLC reports a 7.6% stake in ORIC Pharmaceuticals, Inc.
02/09/2023 SC 13G/A FMR LLC reports a 10.1% stake in ORIC PHARMACEUTICALS INC
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2023 SC 13G MILLENNIUM MANAGEMENT LLC reports a 5.4% stake in ORIC PHARMACEUTICALS, INC.
01/09/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones"
12/29/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/29/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
12/27/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/21/2022 8-K Quarterly results
12/21/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy